Recently, studies have shown that polymorphisms in CDH13 gene could lead to aberrant methylation of the CDH13 promoter and influence plasma adiponectin level which have been demonstrated to be as biomarkers of LC [22–24]. The gene discussed is CDH13; the disease is laryngotracheoesophageal cleft.